RS

Rekha Singh

Active Director Designated Partner DIN 10416011
DIN 10416011 First appointment Dec 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rekha Singh

Data last updated:

Rekha Singh is a Designated Partner at Srk Pharma Llp (since 2023). The company operates in Business Services.

DIN 10416011
Primary Designation Designated Partner
Industry Business Services
First Appointment 05 Dec 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Srk Pharma Llp ACA-0684
Designated Partner05 Dec 20232023Active

Board colleagues of Rekha Singh

NameDINCompanyDesignation
Anshu Yadav10381335Srk Pharma LlpDesignated Partner
Sanjay Ramsakal Yadav10379313Srk Pharma LlpDesignated Partner
Yasar Naushad Akram10379241Srk Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Srk Pharma Llp
Premium access

Shareholding and investment profile for Rekha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Singh

Rekha Singh currently holds 1 directorship: Srk Pharma Llp (Designated Partner, since 05 Dec 2023).

Rekha Singh was first appointed on 05 Dec 2023 as Designated Partner at Srk Pharma Llp.

The current boards of Rekha Singh's companies include Anshu Yadav (Srk Pharma Llp), Sanjay Ramsakal Yadav (Srk Pharma Llp), Yasar Naushad Akram (Srk Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available